Nexaph Ipamorelin
As of 9 Aug 2026, Finnrick has published 10 independent lab tests of Ipamorelin from Nexaph: 5 passed and 5 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 6 Jun 2026. The current Finnrick rating for Nexaph Ipamorelin is 60%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 6 Jun 2026 | Pass | Certificate pndbdcp |
| 16 Feb 2026 | Fail | Certificate vku5qr7 |
| 15 Feb 2026 | Pass | Certificate p3t2jay |
| 7 Jan 2026 | Pass | Certificate 65fydcw |
| 16 Dec 2025 | Pass | Certificate wcdgs3m |
| 18 Nov 2025 | Pass | Certificate vjjrkkp |
| 31 Oct 2025 | Fail | Certificate 4kvwzt3 |
| 30 Oct 2025 | Fail | Certificate sq3buqu |
| 2 Oct 2025 | Fail | Certificate zfhsnxf |
| 3 Jul 2025 | Fail | Certificate nh9s57j |